您的位置：
首页
>
农业专利
>
详情页
QUINOXALINEDIONE DERIVATIVES
专利权人:
MERCK PATENT GMBH
发明人:
CRAVO, DANIEL,HALLAKOU-BOZEC, SOPHIE,LEPIFRE, FRANCK
申请号：
NZ59050309
公开号：
NZ590503A
申请日:
2009.05.19
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Disclosed are hydroquinoxaline-2,3-dione compounds. The compounds are used to treat metabolic syndrome, diabetes, obesity, cancer, inflammation or cardiovascular diseases.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY
TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMERS DISEASE AND INFLAMMATORY BOWEL DISEASE BY USING AT LEAST ONE BACTERIAL STRAIN FROM PREVOTELLA
TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY BOWEL DISEASE BY USING AT LEAST ONE BACTERIAL STRAIN FROM PREVOTELLA
Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from Prevotella
Treatment of obesity, metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, Alzheimer's disease and inflammatory bowel disease using at least one bacterial strain of Prevotella
